Eris Lifesciences Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Share holding
• Capital structures
• Ratio

Sep' 24	Jun' 24	Mar' 24	Dec' 23	Sep' 23

Sales

428.75

456.69

341.30

324.41

409.71

Operating profit

134.82

123.38

79.39

74.43

144.49

Interest

56.26

56.17

28.89

15.14

6.55

Gross profit

92.18

72.37

70.89

62.73

144.92

EPS (Rs)

2.06

1.25

2.90

2.33

8.66

Other income

13.62

5.16

20.39

3.43

6.98

Stock adjustment

-10.20

-14.29

10.40

4.65

-2.95

Raw material

23.19

24.40

17.74

23.75

28.64

Power and fuel

-

-

-

-

-

Employee expenses

89.72

103.75

79.52

80.69

81.10

Excise

-

-

-

-

-

Admin and selling expenses

-

-

-

-

-

Research and development expenses

-

-

-

-

-

Expenses capitalised

-

-

-

-

-

Other expenses

191.22

219.45

154.25

140.90

158.44

Provisions made

-

-

-

-

-

Depreciation

46.16

45.55

29.14

28.08

25.00

Taxation

17.92

9.78

2.24

2.99

2.11

Net profit / loss

28.10

17.04

39.51

31.66

117.81

Extra ordinary item

-

-

-

-

-

Prior year adjustments

-

-

-

-

-

Equity capital

13.61

13.61

13.60

13.60

13.60

Equity dividend rate

-

-

-

-

-

Agg.of non-prom. shares (Lacs)

-

-

-

-

-

Agg.of non promotoholding (%)

-

-

-

-

-

OPM (%)

31.44

27.02

23.26

22.94

35.27

GPM (%)

20.84

15.67

19.60

19.13

34.78

NPM (%)

6.35

3.69

10.92

9.66

28.27